World’s first primary standard developed for molecular radiotherapy

Researchers at the National Physical Laboratory have developed the world’s first primary standard for molecular radiotherapy to ensure its safe, effective use in the treatment of cancer. The new standard will help improve the consistency of treatments with MRT, in which radioactive molecules, or radiopharmaceuticals, are injected directly into a patient’s body to target and kill cancerous cells. Such standardisation is vital to encouraging more widespread use of MRT and the development of new and improved radiopharmaceuticals.